TLPH
Talphera, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.20
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 34.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.32x
- Price / sales
- —
- Price / cash flow
- -5.08x
Enterprise value
- Enterprise value
- $45.2M
- EV / sales
- —
- EV / EBITDA
- -3.20x
- EV / EBIT
- -3.07x
- Market cap
- $62.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026